NGEN CIK: 1751912

NervGen Pharma Corp.

  • Canada
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY24
FY25
FY24 – FY25

Assets

(positive)
Change from FY24 to FY25
millions CAD
FY24:
19.0
FY25:
22.8
(positive)
Change from FY24 to FY25
millions CAD
FY24:
0.47
FY25:
0.41
Total assets
Change from FY24 to FY25
millions CAD
FY24:
19.5
FY25:
23.2

Liabilities & Equity

(negative)
Change from FY24 to FY25
millions CAD
FY24:
16.9
FY25:
19.7
(negative)
Change from FY24 to FY25
millions CAD
FY24:
0.01
FY25:
0
(positive)
Change from FY24 to FY25
millions CAD
FY24:
2.58
FY25:
3.48
Total liabilities & equity
Change from FY24 to FY25
millions CAD
FY24:
19.5
FY25:
23.2

All amounts in millions CAD Data source:SEC EDGAR